Lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled study.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Clinical Psychiatry

• Publication date

  2013-07-15

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.4088/JCP.12m08144PMID 23945447
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinically Relevant Changes in Emotional Expression in Children With ADHD Treated With Lisdexamfetamine Dimesylate

  2012cited by this paper
• Understanding the Effect Size of Lisdexamfetamine Dimesylate for Treating ADHD in Children and Adults

  2012cited by this paper
• Understanding the Effects of Stimulant Medications on Cognition in Individuals with Attention-Deficit Hyperactivity Disorder: A Decade of Progress

  2011cited by this paper
• Effect of Atomoxetine on Executive Function Impairments in Adults With ADHD

  2011cited by this paper
• Are stimulants effective in the treatment of executive function deficits? Results from a randomized double blind study of OROS-methylphenidate in adults with ADHD.

  2011cited by this paper
• Predicting Impairment in Major Life Activities and Occupational Functioning in Hyperactive Children as Adults: Self-Reported Executive Function (EF) Deficits Versus EF Tests

  2011cited by this paper
• A Critical Review of ADHD Diagnostic Criteria: What to Address in the DSM-V

  2011cited by this paper
• Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design

  2010cited by this paper
• Structure and diagnosis of adult attention-deficit/hyperactivity disorder: analysis of expanded symptom criteria from the Adult ADHD Clinical Diagnostic Scale.

  2010cited by this paper
• Open-Label Administration of Lisdexamfetamine Dimesylate Improves Executive Function Impairments and Symptoms of Attention-Deficit/Hyperactivity Disorder in Adults

  2010cited by this paper
• Attention deficit hyperactivity disorder in adults

  2010cited by this paper
• Improvements in Executive Function Correlate with Enhanced Performance and Functioning and Health-Related Quality of Life: Evidence from 2 Large, Double-Blind, Randomized, Placebo-Controlled Trials in ADHD

  2010cited by this paper
• Executive Function Deficits in Children with Attention-Deficit/Hyperactivity Disorder and Improvement with Lisdexamfetamine Dimesylate in an Open-Label Study

  2010cited by this paper
• Long-Term Safety and Effectiveness of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder

  2009cited by this paper
• Executive Function Impairments in High IQ Adults With ADHD

  2009cited by this paper
• Efficacy and Safety of OROS Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Dose-Escalation Study

  2009cited by this paper
• Discordance Between Psychometric Testing and Questionnaire-Based Definitions of Executive Function Deficits in Individuals With ADHD

  2008cited by this paper
• Reliability, Validity, and Utility of Instruments for Self-Report and Informant Report Concerning Symptoms of ADHD in Adult Patients

  2008cited by this paper
• Effects of stimulant medication on neuropsychological functioning in young adults with attention-deficit/hyperactivity disorder.

  2008cited by this paper
• Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.

  2008cited by this paper
• Stability of executive function deficits into young adult years: a prospective longitudinal follow‐up study of grown up males with ADHD

  2007cited by this paper
• Can Self-Reported Behavioral Scales Assess Executive Function Deficits?: A Controlled Study of Adults With ADHD

  2007cited by this paper
• Stability of Executive Function Deficits in Girls with ADHD: A Prospective Longitudinal Followup Study into Adolescence

  2007cited by this paper
• The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication.

  2006cited by this paper
• Characterizing cognition in ADHD: beyond executive dysfunction.

  2006cited by this paper
• Mixed Amphetamine Salts Extended-Release in the Treatment of Adult ADHD: A Randomized, Controlled Trial

  2006cited by this paper
• Impact of psychometrically defined deficits of executive functioning in adults with attention deficit hyperactivity disorder.

  2006cited by this paper
• Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community.

  2006cited by this paper
• A Randomized, Placebo-Controlled Trial of OROS Methylphenidate in Adults with Attention-Deficit/Hyperactivity Disorder

  2006cited by this paper
• Causal heterogeneity in attention-deficit/hyperactivity disorder: do we need neuropsychologically impaired subtypes?

  2005cited by this paper
• Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review.

  2005cited by this paper
• The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies

  2005cited by this paper
• A guide to the treatment of adults with ADHD.

  2004cited by this paper
• Impact of executive function deficits and attention-deficit/hyperactivity disorder (ADHD) on academic outcomes in children.

  2004cited by this paper
• Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder.

  2004cited by this paper
• Confirmatory Factor Analysis of the Behavior Rating Inventory of Executive Function (BRIEF) in a Clinical Sample

  2002cited by this paper
• Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD.

  1997cited by this paper
• Deficits in strategy application following frontal lobe damage in man.

  1991cited by this paper

• Nasal Adverse Events Associated With Attention-Deficit Hyperactivity Disorder (ADHD) Medications: A Systematic Review, Meta-Analysis, and Implications for the Otolaryngologist

  2025influential citation
• Effect of amphetamines on blood pressure.

  2025cites this paper
• Neurobiologija poremećaja pažnje i hiperaktivnosti

  2025cites this paper
• Role of vesicular monoamine transporter-2 for treating attention deficit hyperactivity disorder: a review

  2024cites this paper
• Differential Outcomes of Placebo Treatment Across 9 Psychiatric Disorders: A Systematic Review and Meta-Analysis.

  2024cites this paper
• Do ADHD Treatments Improve Executive Behavior Beyond Core ADHD Symptoms in Adults? Evidence From Systematic Analysis of Clinical Trials

  2023cites this paper
• An overview on neurobiology and therapeutics of attention-deficit/hyperactivity disorder

  2023cites this paper
• Pilot Study of Prism EFP NeuroFeedback in Adult ADHD

  2023cites this paper
• Revisiting stimulant use for emotional dysregulation in attention-deficit/hyperactivity disorder (ADHD)

  2023cites this paper
• What value do norepinephrine/dopamine dual reuptake inhibitors have to the current treatment of adult attention deficit hyperactivity disorder (ADHD) treatment armamentarium?

  2022cites this paper
• Risk of Major Cardiovascular and Cerebrovascular Events in Users of Lisdexamfetamine and Other Medications for Attention-Deficit/Hyperactivity Disorder in Denmark and Sweden: A Population-Based Cohort Study

  2022cites this paper
• Do Treatments for Adult ADHD Improve Emotional Behavior? A Systematic Review and Analysis

  2022influential citation
• A Placebo-Controlled Trial of Lisdexamfetamine in the Treatment of Comorbid Sluggish Cognitive Tempo and Adult ADHD.

  2021cites this paper
• Efficacy of Amphetamines, Methylphenidate, and Modafinil in the Treatment of Mental Disorders

  2021cites this paper
• Subjective cognition in adults with common psychiatric classifications; a systematic review.

  2021cites this paper
• Half of the children with overweight or obesity and attention‐deficit/hyperactivity disorder reach normal weight with stimulants

  2021cites this paper
• Improved Executive Function in Adults Diagnosed With Attention-Deficit/ Hyperactivity Disorder as Measured by the Brown Attention-Deficit Disorder Scale Following Treatment With SHP465 Mixed Amphetamine Salts Extended-Release: Post Hoc Analyses From 2 Randomized, Placebo-Controlled Studies

  2020cites this paper
• Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis

  2020cites this paper
• Development of the Korean Practice Parameter for Adult Attention-Deficit/Hyperactivity Disorder

  2020cites this paper
• Relationships Between Executive Function Improvement and ADHD Symptom Improvement With Lisdexamfetamine Dimesylate in Adults With ADHD and Executive Function Deficits: A Post Hoc Analysis.

  2020cites this paper
• A Controlled Trial of Extended-Release Guanfacine and Psychostimulants on Executive Function and ADHD

  2020cites this paper
• The Effectiveness of Stimulant Medication at Improving Executive Functioning in Adults with ADHD

  2020cites this paper
• A Controlled Trial of Extended-Release Guanfacine and Psychostimulants on Executive Function and ADHD.

  2020cites this paper
• Current and emerging pharmacotherapy for the treatment of adult attention deficit hyperactivity disorder (ADHD)

  2019cites this paper
• Validation of the Expanded Versions of the Adult ADHD Self-Report Scale v1.1 Symptom Checklist and the Adult ADHD Investigator Symptom Rating Scale

  2019cites this paper
• Maternal executive function and the family food environment.

  2019cites this paper
• Investigation in the overlap of ADHD and borderline personality disorder : a multi-modal approach

  2019cites this paper
• A phase 1, randomized, double‐blind, placebo‐controlled study to evaluate the safety, tolerability, and pharmacokinetics of single and multiple doses of lisdexamfetamine dimesylate in Japanese and Caucasian healthy adult subjects

  2019cites this paper
• Safety of Treatments for ADHD in Adults: Pairwise and Network Meta-Analyses

  2019cites this paper
• Practitioner Review: Emotional dysregulation in attention-deficit/hyperactivity disorder - implications for clinical recognition and intervention.

  2019cites this paper
• Pharmacotherapy of emotional dysregulation in adults with ADHD: A systematic review and meta‐analysis

  2018influential citation
• Moody Adults with ADHD

  2018cites this paper
• Updated European Consensus Statement on diagnosis and treatment of adult ADHD

  2018cites this paper
• Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.

  2018cites this paper
• Efficacy, Acceptability, and Tolerability of Lisdexamfetamine, Mixed Amphetamine Salts, Methylphenidate, and Modafinil in the Treatment of Attention-Deficit Hyperactivity Disorder in Adults: A Systematic Review and Meta-analysis

  2018cites this paper
• The Relationship Between Executive Function Deficits and DSM-5-Defined ADHD Symptoms

  2018cites this paper
• Social contextual risk factors for stimulant use among adolescent American Indians.

  2017cites this paper
• Effects of stimulants and atomoxetine on emotional lability in adults: A systematic review and meta-analysis

  2017cites this paper
• Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder

  2017influential citation
• Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe

  2017cites this paper
• Treatment With Lisdexamfetamine Dimesylate Improves Self- and Informant-Rated Executive Function Behaviors and Clinician- and Informant-Rated ADHD Symptoms in Adults: Data From a Randomized, Double-Blind, Placebo-Controlled Study

  2017cites this paper
• Pharmacologic and Pharmacokinetic Aspects Lisdexamfetamine dimesylate is a water-soluble prodrug of the single isomer—d-amphetamine and l-lysine—that remains Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder

  2017cites this paper
• Pharmacokinetic and Pharmacodynamic Properties of Lisdexamfetamine in Adults with Attention-Deficit/Hyperactivity Disorder

  2017cites this paper
• Persisting Psychosocial Impairments in Adults Being Treated with Medication for Attention Deficit/Hyperactivity Disorder.

  2017cites this paper
• Effect of Parent Management Training on Attention, Response Prevention, Impulsivity and Vigilance of Boys with Attention Deficient/Hyperactive Disorder

  2017cites this paper
• of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit / hyperactivity disorder

  2017influential citation
• Alternative pharmacological strategies for adult ADHD treatment: a systematic review

  2016cites this paper
• Prescription stimulant medication misuse: Where are we and where do we go from here?

  2016cites this paper
• Attention-defi cit hyperactivity disorder 2 Adult attention-defi cit hyperactivity disorder: key conceptual issues

  2016cites this paper
• Adult attention-deficit hyperactivity disorder: key conceptual issues.

  2016cites this paper
• Lisdexamfetamine: A Review in ADHD in Adults

  2016cites this paper
• Lisdexamfetamine Dimesylate: Prodrug Delivery, Amphetamine Exposure and Duration of Efficacy

  2016cites this paper
• Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial.

  2015cites this paper
• Lisdexamfetamindimesilat bei ADHS

  2015influential citation
• Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD

  2014influential citation
• Preclinical pharmacology of amphetamine: implications for the treatment of neuropsychiatric disorders.

  2014cites this paper
• Therapeutic Class Overview Attention Deficit/Hyperactivity Disorder (ADHD) Agents and Stimulants

  2014cites this paper
• Clinical Effects of Lisdexamfetamine and Mixed Amphetamine Salts Immediate Release in Adult ADHD: Results of a Crossover Design Clinical Trial

  2014cites this paper
• A Systematic Review of the Safety of Lisdexamfetamine Dimesylate

  2014cites this paper
• Associations of sleep disturbance with ADHD: implications for treatment

  2014cites this paper
• exploratory meta-analysis on lisdexamfetamine versus placebo in adult aDhD

  2014influential citation
• The use of lisdexamfetamine dimesylate for the treatment of ADHD and other psychiatric disorders

  2014cites this paper
• Double-Blind , Placebo-Controlled Study Behaviors and Clinician-and Informant-Rated ADHD Symptoms in Adults : Data From a Randomized , Treatment With Lisdexamfetamine Dimesylate Improves Self-and Informant-Rated Executive Function

  2014cites this paper
• Atomoxetine Effects on Executive Function as Measured by the BRIEF-A in Young Adults with ADHD: A Randomized, Double-Blind, Placebo-Controlled Study

  2014cites this paper
• Self-Reported quality of life in adults with attention-deficit/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: a randomized, double-blind, multicenter, placebo-controlled, parallel-group study

  2013cites this paper
• Psychology Research and Behavior Management Dovepress Pharmacological Interventions for Adolescents and Adults with Adhd: Stimulant and Nonstimulant Medications and Misuse of Prescription Stimulants

  year unknowncites this paper